Colorectal Cancer

Clinical practice guidelines updated

Published in Cancer Weekly, May 11th, 2004

The National Comprehensive Cancer Network (NCCN), an alliance of 19 cancer centers, has updated its "NCCN Colorectal Clinical Practice Guidelines."

NCCN's Colon, Rectal, and Anal Cancer panel met recently to discuss incorporation of two newly approved agents into treatment regimens for advanced colon and rectal cancer and to modify recommendations for adjuvant therapy for node-positive colon cancer.

For first line therapy of advanced colon and rectal cancer, in patients who can tolerate intensive chemotherapy, the panel added recommendations for regimens using bevacizumab (Avastin; Genentech) in combination with 5-FU based regimens including those...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2004-05-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry